{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T23:35:06Z","timestamp":1783121706925,"version":"3.54.6"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.lungcan.2022.12.008","type":"journal-article","created":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T20:19:40Z","timestamp":1671653980000},"page":"24-30","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Clinical impact of histologic type on survival and recurrence in patients with surgically resected stage II and III non-small cell lung cancer"],"prefix":"10.1016","volume":"176","author":[{"given":"Jae Kwang","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelee","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Dong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehoon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeong Ryul","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Kwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Il","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2022.12.008_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"5","key":"10.1016\/j.lungcan.2022.12.008_b0010","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/JTO.0b013e3181d2dcd9","article-title":"Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC","volume":"5","author":"Kawaguchi","year":"2010","journal-title":"J. Thorac. Oncol."},{"key":"10.1016\/j.lungcan.2022.12.008_b0015","doi-asserted-by":"crossref","unstructured":"K. Chansky, J.P. Sculier, J.J. Crowley, D. Giroux, J. Van Meerbeeck, P. Goldstraw, C. International Staging, I. Participating, The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer, J. Thorac. Oncol. 4(7) (2009) 792-801.","DOI":"10.1097\/JTO.0b013e3181a7716e"},{"issue":"12","key":"10.1016\/j.lungcan.2022.12.008_b0020","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0b013e318189f551","article-title":"The prognostic and predictive role of histology in advanced non-small cell lung cancer: a literature review","volume":"3","author":"Hirsch","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.008_b0025","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.lungcan.2014.01.009","article-title":"International trends in lung cancer incidence by histological subtype: adenocarcinoma stabilizing in men but still increasing in women","volume":"84","author":"Lortet-Tieulent","year":"2014","journal-title":"Lung Cancer"},{"issue":"45","key":"10.1016\/j.lungcan.2022.12.008_b0030","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.3346\/jkms.2019.34.e291","article-title":"Recent Trends in Demographics, Surgery, and Prognosis of Patients with Surgically Resected Lung Cancer in a Single Institution from Korea","volume":"34","author":"Yun","year":"2019","journal-title":"J. Korean Med. Sci."},{"issue":"4","key":"10.1016\/j.lungcan.2022.12.008_b0035","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s10147-010-0160-8","article-title":"Non-small cell lung cancer in never smokers as a representative 'non-smoking-associated lung cancer': epidemiology and clinical features","volume":"16","author":"Yano","year":"2011","journal-title":"Int. J. Clin. Oncol."},{"issue":"21","key":"10.1016\/j.lungcan.2022.12.008_b0040","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa040938","article-title":"Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib","volume":"350","author":"Lynch","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"5676","key":"10.1016\/j.lungcan.2022.12.008_b0045","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1099314","article-title":"EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy","volume":"304","author":"Paez","year":"2004","journal-title":"Science"},{"issue":"18","key":"10.1016\/j.lungcan.2022.12.008_b0050","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1056\/NEJMoa1006448","article-title":"Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer","volume":"363","author":"Kwak","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lungcan.2022.12.008_b0055","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.lungcan.2019.12.007","article-title":"Survival disparities following surgery among patients with different histological types of non-small cell lung cancer","volume":"140","author":"Grosu","year":"2020","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.008_b0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1093\/ejcts\/ezaa042","article-title":"Long-term outcomes of upfront surgery in patients with resectable pathological N2 non-small-cell lung cancer","volume":"58","author":"Yun","year":"2020","journal-title":"Eur. J. Cardiothorac. Surg."},{"key":"10.1016\/j.lungcan.2022.12.008_b0065","doi-asserted-by":"crossref","unstructured":"F.C. Detterbeck, D.J. Boffa, A.W. Kim, L.T. Tanoue, The Eighth Edition Lung Cancer Stage Classification, Chest 151(1) (2017) 193-203.","DOI":"10.1016\/j.chest.2016.10.010"},{"issue":"2","key":"10.1016\/j.lungcan.2022.12.008_b0070","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jtcvs.2010.06.044","article-title":"Risk model of in-hospital mortality after pulmonary resection for cancer: a national database of the French Society of Thoracic and Cardiovascular Surgery (Epithor)","volume":"141","author":"Bernard","year":"2011","journal-title":"J. Thorac. Cardiovasc. Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2022.12.008_b0075","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A Class of K-Sample Tests for Comparing the Cumulative Incidence of a Competing Risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann. Statist."},{"issue":"446","key":"10.1016\/j.lungcan.2022.12.008_b0080","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A Proportional Hazards Model for the Subdistribution of a Competing Risk","volume":"94","author":"Fine","year":"1999","journal-title":"J. Am. Stat. Assoc."},{"issue":"12","key":"10.1016\/j.lungcan.2022.12.008_b0085","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1097\/JTO.0000000000000691","article-title":"A Prognostic Model to Predict Mortality among Non\u2013Small-Cell Lung Cancer Patients in the U.S. Military Health System","volume":"10","author":"Lin","year":"2015","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.lungcan.2022.12.008_b0090","first-page":"455","article-title":"Parsimonious Eurolung risk models to predict cardiopulmonary morbidity and mortality following anatomic lung resections: an updated analysis from the European Society of Thoracic Surgeons database","volume":"57","author":"Brunelli","year":"2020","journal-title":"Eur. J. Cardiothorac. Surg."},{"issue":"7","key":"10.1016\/j.lungcan.2022.12.008_b0095","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/JTO.0b013e318219aae2","article-title":"Japanese Joint Committee for Lung Cancer, Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade","volume":"6","author":"Sawabata","year":"2011","journal-title":"J. Thorac. Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.008_b0100","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1097\/JTO.0b013e31815e8577","article-title":"A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers","volume":"3","author":"Asamura","year":"2008","journal-title":"J. Thorac. Oncol."},{"issue":"6","key":"10.1016\/j.lungcan.2022.12.008_b0105","first-page":"291","article-title":"Difference in Postsurgical Prognostic Factors between Lung Adenocarcinoma and Squamous Cell Carcinoma, Annals of thoracic and cardiovascular surgery: official journal of the Association of Thoracic and Cardiovascular Surgeons of","volume":"23","author":"Nakamura","year":"2017","journal-title":"Asia"},{"issue":"9","key":"10.1016\/j.lungcan.2022.12.008_b0110","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","article-title":"Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial","volume":"7","author":"Douillard","year":"2006","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.lungcan.2022.12.008_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.lungcan.2011.02.004","article-title":"Impact of histology on survival of resected non-small cell lung cancer (NSCLC) receiving adjuvant chemotherapy: subgroup analysis of the adjuvant vinorelbine (NVB) cisplatin (CDDP) versus observation in the ANITA trial","volume":"74","author":"Bennouna","year":"2011","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222007176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222007176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:02:19Z","timestamp":1759237339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222007176"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":23,"alternative-id":["S0169500222007176"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.12.008","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical impact of histologic type on survival and recurrence in patients with surgically resected stage II and III non-small cell lung cancer","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}